Ausgabe 4/1998
Inhalt (12 Artikel)
Metabolism and ribonucleotide reductase inhibition of (E )-2′-deoxy-2′-(fluoromethylene)cytidine, MDL 101,731, in human cervical carcinoma HeLa S3 cells
Takeshi Takahashi, Akiko Nakashima, Junji Kanazawa, Kazuo Yamaguchi, Shiro Akinaga, Tatsuya Tamaoki, Masami Okabe
Preclinical pharmacology of the natural product anticancer agent 10-hydroxycamptothecin, an inhibitor of topoisomerase I
Ruiwen Zhang, Yufeng Li, Qiuyin Cai, Tiepu Liu, He Sun, Brandon Chambless
Effect of 5-aza-2′-deoxycytidine and vitamin D3 analogs on growth and differentiation of human myeloid leukemic cells
Benoit T. Doré, Christine Chomienne, Richard L. Momparler
Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors
Brigitte Tranchand, Gilles Catimel, Catherine Lucas, Marlis Sarkany, Gérard Bastian, Eric Evene, Jean-Paul Guastalla, Sylvie Négrier, Paul Rebattu, Arlette Dumortier, Maurice Foy, François Grossin, Béatrice Mazier, Marios Froudarakis, Nicolas Barbet, Michel Clavel, Claude Ardiet
The antiproliferative action of a melphalan hexapeptide with collagenase-cleavable site
F. Timár, J. Botyánszki, H. Süli-Vargha, I. Babó, J. Oláh, G. Pogány, A. Jeney
Quantitation of dolastatin-10 using HPLC/electrospray ionization mass spectrometry: application in a phase I clinical trial
D. A. Garteiz, T. Madden, D. E. Beck, W. R. Huie, K. T. McManus, J. L. Abbruzzese, W. Chen, R. A. Newman
Synergistic cytotoxicity of cisplatin and topotecan or SN-38 in a panel of eight solid-tumor cell lines in vitro
Jianguo Ma, Marc Maliepaard, Kees Nooter, Antonius W. M. Boersma, Jaap Verweij, Gerrit Stoter, Jan H. M. Schellens
The antineoplastic ether lipid, s-phosphonate, selectively induces apoptosis in human leukemic cells and exhibits antiangiogenic and apoptotic activity on the chorioallantoic membrane of the chick embryo
John K. Jackson, Helen M. Burt, Ann Marie Oktaba, William Hunter, Michael P. Scheid, Fatima Mouhajir, Ron W. Lauener, Yaping Shen, Hassan Salari, Vincent Duronio, Ann Marie Oktaba
Cisplatin, epirubicin, and lonidamine combination regimen as first-line chemotherapy for metastatic breast cancer: a pilot study
L. Dogliotti, S. Danese, A. Berruti, P. Zola, T. Buniva, A. Bottini, G. Richiardi, G. Moro, A. Farris, M. G. Baù, G. Porcile
Distribution of estramustine in the BT4C rat glioma model
M. Johansson, A. Tommy Bergenheim, Roland D’Argy, Karin Edman, Per-Olov Gunnarsson, Anders Widmark, Roger Henriksson
Length increase of the side chain of idoxifene does not improve its antagonistic potency in breast-cancer cell lines
Lu Jin, Nicole Legros, Guy Leclercq, Ian R. Hardcastle, Michael Jarman
Effects of haemopoietic growth factors in combination with etoposide on sister chromatid exchange frequencies in peripheral blood mononuclear cells
Wai M. Liu, Clare Bamford, Maurice Slevin, Simon P. Joel